🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% ...
Status
Terminated
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT00764582
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of t...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-19
Trial ID
NCT02298179
Treatments Being Tested
Effects of Message framing and Time discounting on heath communication for ...
Status
Completed
Location
Health center of Sipo town
Start Date
2020-07-01
Trial ID
NCT04450888
Treatments Being Tested
Knee osteoarthritis (OA) is the most common form of arthritis and the most ...
Status
Completed
Location
The University of Nottingham, City Hospital Campus
Start Date
2020-11-06
Trial ID
NCT04443452
In 2012, the World Health Assembly (WHA) endorsed the proposed Polio Endgam...
Status
Completed
Location
International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Kamalapur Field office, Lichubagan Rd
Start Date
2024-05-09
Trial ID
NCT06413121
This is a phase 1 study to assess the safety and immunogenicity of differen...
Status
Completed
Location
Josha Research
Start Date
2022-05-30
Trial ID
NCT05228314
This study includes 3 parts: Parts A, B, and C. The purpose of this study i...
Status
Completed
Location
Pinnacle Research Group
Start Date
2023-04-17
Trial ID
NCT05827978
Treatments Being Tested
This will be a randomized single-blind controlled trial to determine the im...
Status
Completed
Location
Hospital Ampang
Start Date
2022-09-20
Trial ID
NCT05517642
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested
This clinical study will assess the safety, reactogenicity and immunogenici...
Status
Completed
Location
Research Centers of America
Start Date
2017-11-13
Trial ID
NCT03382405